Substituted heterocycles and methods of use

Details for Australian Patent Application No. 2007338792 (hide)

Owner Amgen Inc.

Inventors Lee, Matthew; Fellows, Ingrid M.; Norman, Mark H.; Liu, Longbin; Bellon, Steven; Harmange, Jean-Christophe; Kim, Tae-Seong; Booker, Shon; D'Angelo, Noel

Agent Shelston IP

Pub. Number AU-B-2007338792

PCT Pub. Number WO2008/079291

Priority 60/876,388 20.12.06 US

Filing date 19 December 2007

Wipo publication date 3 July 2008

Acceptance publication date 31 May 2012

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

18 June 2009 PCT application entered the National Phase

  PCT publication WO2008/079291 Priority application(s): WO2008/079291

31 May 2012 Application Accepted

  Published as AU-B-2007338792

27 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007338793-Heterocyclic compounds and their use in treating inflammation, angiogenesis and cancer

2007338791-Stable buffered formulations containing polypeptides